EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Macrophage CREBZF Orchestrates Inflammatory Response to Potentiate Insulin Resistance and Type 2 Diabetes

Yuxiao Liu, Weitong Su, Zhengshuai Liu, Zhimin Hu, Jiaxin Shen, Zengpeng Zheng, Dong Ding, Wei Huang, Wenjing Li, Genxiang Cai, Shuang Wei, Ni Li und 9 weitere

Advanced Science · 2024

DOI: 10.1002/advs.202306685 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Yuxiao Liu und 20 weiteren Autor:innen. Beteiligte Einrichtung: CAS Key Laboratory of Nutrition, Metabolism and Food Safety, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, C…. Hauptthemen laut MEDLINE: Basic-Leucine Zipper Transcription Factors, Diabetes Mellitus, Type 2, Insulin Resistance. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Shanghai Municipal Science and Technology Major Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic adipose tissue inflammation accompanied by macrophage accumulation and activation is implicated in the pathogenesis of insulin resistance and type 2 diabetes in humans. The transcriptional coregulator CREBZF is a key factor in hepatic metabolism, yet its role in modulating adipose tissue inflammation and type 2 diabetes remains elusive. The present study demonstrates that overnutrition‐induced CREBZF links adipose tissue macrophage (ATM) proinflammatory activation to insulin resistance. CREBZF deficiency in macrophages, not in neutrophils, attenuates macrophage infiltration in adipose, proinflammatory activation, and hyperglycemia in diet‐induced insulin‐resistant mice. The coculture assays show that macrophage CREBZF deficiency improves insulin sensitivity in primary adipocytes and adipose tissue. Mechanistically, CREBZF competitively inhibits the binding of IκBα to p65, resulting in enhanced NF‐κB activity. In addition, bromocriptine is identified as a small molecule inhibitor of CREBZF in macrophages, which suppresses the proinflammatory phenotype and improves metabolic dysfunction. Furthermore, CREBZF is highly expressed in ATM of obese humans and mice, which is positively correlated with proinflammatory genes and insulin resistance in humans. This study identifies a previously unknown role of CREBZF coupling ATM activation to systemic insulin resistance and type 2 diabetes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Basic-Leucine Zipper Transcription FactorsDiabetes Mellitus, Type 2Insulin ResistanceAnimalsHumansMiceAdipose TissueInflammationMacrophagesObesity

Stichwörter der Autor:innen

CREBZFNF‐κBadipose tissue macrophagechronic inflammationtype 2 diabetes

Substanzen

Basic-Leucine Zipper Transcription FactorsCREBZF protein, humanSMILE protein, mouse

Autor:innen und Institutionen

  • CAS Key Laboratory of Nutrition, Metabolism and Food Safety, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, 200031, China.
  • Department of Endocrinology and Metabolism, The Affiliated Hospital of Southwest Medical University, Metabolic Vascular Diseases Key Laboratory of Sichuan Province, Luzhou, Sichuan, 646000, China.
  • CAS Key Laboratory of Tissue Microenvironment and Tumor, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, 200031, China.
  • CAS Key Laboratory of Computational Biology, Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences, Shanghai, 200031, China.
  • Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, Jiangsu, 210008, China.
  • Metabolic Vascular Disease Key Laboratory of Sichuan Province, The Affiliated Hospital of Southwest Medical University, Key Laboratory of Medical Electrophysiology, Ministry of Education, Southwest Medical University, L…

ORCID-Profile: Yu Li

Förderung

  • National Natural Science Foundation of China
  • National Key Research and Development Program of China
  • Shanghai Municipal Science and Technology Major Project
  • Metabolic Vascular Diseases Key Laboratory of Sichuan Province

Zitieren

APA

Liu, Y., Su, W., Liu, Z., Hu, Z., Shen, J., Zheng, Z., Ding, D., Huang, W., Li, W., Cai, G., Wei, S., Li, N., Fang, X., Li, H., Qin, J., Zhang, H., Xiao, Y., Bi, Y., Cui, A., …, & Li, Y. (2024). Macrophage CREBZF Orchestrates Inflammatory Response to Potentiate Insulin Resistance and Type 2 Diabetes. Advanced Science. https://doi.org/10.1002/advs.202306685

Vancouver

Liu Y, Su W, Liu Z, Hu Z, Shen J, Zheng Z, et al. Macrophage CREBZF Orchestrates Inflammatory Response to Potentiate Insulin Resistance and Type 2 Diabetes. Advanced Science. 2024. doi:10.1002/advs.202306685

BibTeX
@article{Liu2024,
  author = {Liu, Yuxiao and Su, Weitong and Liu, Zhengshuai and Hu, Zhimin and Shen, Jiaxin and Zheng, Zengpeng and Ding, Dong and Huang, Wei and Li, Wenjing and Cai, Genxiang and Wei, Shuang and Li, Ni and Fang, Xia and Li, Hong and Qin, Jun and Zhang, Haibing and Xiao, Yichuan and Bi, Yan and Cui, Aoyuan and Zhang, Chunxiang and Li, Yu},
  title = {Macrophage CREBZF Orchestrates Inflammatory Response to Potentiate Insulin Resistance and Type 2 Diabetes},
  journal = {Advanced Science},
  year = {2024},
  doi = {10.1002/advs.202306685}
}
Kostenlos starten →